Concept Architecture
Concept
Theoretically, Event-Free Survival is a time-to-event outcome measuring the duration from a defined starting point until the occurrence of a prespecified event, such as disease progression, relapse, treatment failure, secondary malignancy or death. It is founded on survival analysis and combines multiple clinically relevant outcomes into a composite endpoint. In health economics, Event-Free Survival is used to estimate time spent without adverse clinical events and to inform state-transition and partitioned survival models.
Mathematically, Event-Free Survival is represented by the survival function for the time to the first qualifying event. The function gives the probability that an individual remains alive and free from all defined events beyond time t. It is commonly estimated using the Kaplan-Meier estimator and may be modelled parametrically for extrapolation beyond the observed follow-up period.
In practice, Event-Free Survival is measured from randomisation, diagnosis or treatment initiation until the first occurrence of a protocol-defined event or censoring. Health economists use Event-Free Survival curves to estimate event-free health-state occupancy, quality-adjusted life-years, treatment costs and long-term cost-effectiveness, provided that the included events are clearly defined and clinically meaningful.
Purpose
Used to quantify the time patients remain alive without a specified adverse clinical event and to support survival modelling, health-state estimation and economic evaluation.
Mathematical Formulae
Primary Formula
S?(t) = P(T? > t)
where:
S?(t) = Event-Free Survival probability at time t
T? = time to the first qualifying event
t = time
Supporting Formulae
Kaplan-Meier estimator:
??(t) = ???�t (1 ? d?/n?)
where:
d? = number of qualifying events at time t?
n? = number of individuals at risk immediately before time t?
Event-Free Survival time:
T? = min(T?, T?, ?, T?)
where:
T? ? T? = times to the component events included in the composite endpoint
Related Mathematical Methods
- Survival Analysis
- Survival Function
- Kaplan-Meier Estimator
- Composite Endpoint
- Progression-Free Survival
- Disease-Free Survival
- Parametric Survival Model
- Partitioned Survival Model
Example
A clinical trial defines an event as disease progression, relapse, treatment discontinuation because of treatment failure or death. At 24 months, the estimated Event-Free Survival probability is 0.68. This means that 68% of patients are expected to remain alive without experiencing any of the prespecified events for at least 24 months.
Excel Implementation
| Function | Example Formula | Health Economics Application |
|---|---|---|
| MIN | =MIN(B2:E2) | Identify the earliest qualifying event time for each patient. |
| COUNTIFS | =COUNTIFS(EventTimeRange,"<="&A2,EventIndicatorRange,1) | Count qualifying events occurring by a specified time. |
| COUNTIF | =COUNTIF(EventTimeRange,">="&A2) | Estimate the number of patients remaining at risk. |
| PRODUCT | =PRODUCT(SurvivalStepRange) | Calculate cumulative Kaplan-Meier Event-Free Survival probabilities. |
VBA (Optional)
VBA can automate composite event-time derivation, risk-set calculations and Event-Free Survival estimation across patient-level datasets.
Sources
- Kleinbaum DG, Klein M. Survival Analysis: A Self-Learning Text. Springer.
- Collett D. Modelling Survival Data in Medical Research. Chapman & Hall/CRC.
- Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. Wiley.
- Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford University Press.
- NICE. NICE Health Technology Evaluations: The Manual.
Related Concepts (2)
Library
Publications
1
Economic Evaluation in Clinical Trials — Glick, Doshi, Sonnad & Polsky, 2nd Edition ed., 2015 (Oxford University Press)
Practical guidance on conducting cost-effectiveness analyses alongside controlled trials, covering trial design, measurement of costs and quality-adjusted life years, handling censored and missing data, and reporting stochastic uncertainty. Volume 4 in the Handbooks in Health Economic Evaluation series.
BookView source →
Frequently Asked Questions (6)
What is event-free survival?
A time-to-event outcome measured from treatment start until any of a predefined set of significant events, such as progression or death, whichever comes first.
Source: Latimer 2013
What counts as an event in event-free survival?
Event-free survival measures the time from the start of treatment until the first of any predefined set of significant events occurs, and which events count must be specified in advance. Depending on the disease, the set might include disease progression, relapse, the need to switch treatment, or death from any cause. Because the definition bundles several events together, the measure captures a broad notion of remaining well, but its meaning depends entirely on which events were included. A stated event list is therefore part of the endpoint. Fleming and DeMets (1996) discuss such composite endpoints.
Source: Fleming & DeMets 1996
How is event-free survival measured?
Event-free survival is measured from a defined starting point, such as the start of treatment or randomisation, until the first occurrence of any event in the predefined set, such as progression, relapse, or death, with patients who have not experienced any such event by the end of follow-up censored at their last assessment. Survival analysis methods, such as the Kaplan-Meier estimator, are used to estimate it, handling censoring appropriately. The specific events included define what event-free survival captures, so the composite must be clearly specified.
Source: Latimer 2013
Why is event-free survival used?
Event-free survival is used because it combines several important adverse events into a single endpoint capturing the time a patient remains free of all of them, providing a comprehensive measure of treatment benefit that can be reached sooner than overall survival, allowing earlier assessment. It reflects both delaying disease-related events and avoiding death. This makes event-free survival useful in trials where waiting for overall survival would take too long, though its interpretation depends on which events are included and how meaningful avoiding them is to patients.
Source: Latimer 2013
What are the limitations of event-free survival?
The limitations of event-free survival arise because it combines different events, which may vary in severity and importance, into a single endpoint, so a difference in event-free survival may be driven by less serious events and not necessarily reflect a survival or quality-of-life benefit. The composite's meaning depends on which events are included, and inconsistent definitions hinder comparison. As an intermediate endpoint, its relationship to overall survival must be considered. These limitations mean event-free survival is defined clearly and interpreted in light of which events drive any observed difference.
Source: Latimer 2013
How does event-free survival differ from overall survival?
Event-free survival differs from overall survival in that overall survival measures time until death from any cause, a single unambiguous endpoint, while event-free survival measures time until the first of several predefined events, including but not limited to death, so it captures a broader range of adverse outcomes and typically occurs earlier. Event-free survival can therefore be assessed sooner but is a composite whose interpretation depends on the events included, whereas overall survival is definitive but requires longer follow-up. The two provide complementary information on treatment benefit.
Source: Latimer 2013
Trust Record
Verified by Dr Darrin Baines
British health economist
Professional identity: darrinbaines.org
Verification date: 6 Nov 2025
Content version: 1.0.0
Canonical Identity
- Persistent URI
- https://healtheconomics.wiki/concept/event-free-survival
- Term code
- HE-ES-CO-025
Stable URI · Machine-readable · Resolvable · CC BY 4.0